PULMONARY LYMPHOMATOID GRANULOMATOSIS

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting PULMONARY LYMPHOMATOID GRANULOMATOSIS:

# Drug Count
0 MYCOPHENOLATE MOFETIL 10
1 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 10
2 ADALIMUMAB 8
3 ADALIMUMAB-AATY 8
4 ADALIMUMAB-ADAZ 8
5 ADALIMUMAB-FKJP 8
6 METHOTREXATE 8
7 METHOTREXATE SODIUM 8
8 AZATHIOPRINE 7
9 PREDNISONE 7
See all common drugs associated with PULMONARY LYMPHOMATOID GRANULOMATOSIS

PULMONARY LYMPHOMATOID GRANULOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TECLISTAMAB-CQYV 1 0.0004
1 THIOTEPA 4 0.0004
2 ADALIMUMAB-FKJP 8 0.0002
3 ADALIMUMAB-AATY 8 0.0002
4 MELPHALAN HYDROCHLORIDE 4 0.0002
5 ADALIMUMAB-ADAZ 8 0.0001
6 FLUDARABINE PHOSPHATE 4 0.0001
7 AZATHIOPRINE 7 0.0001
8 MYCOPHENOLATE MOFETIL 10 0.0001
9 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 10 0.0001
See all drugs enriched for association with PULMONARY LYMPHOMATOID GRANULOMATOSIS

PULMONARY LYMPHOMATOID GRANULOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 7 0.0001
1 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
2 Alkylating Drug [EPC] 6 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
5 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
6 Corticosteroid [EPC] 7 0.0000
7 Opioid Agonist [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Vitamin B12 [EPC] 1 0.0000
See all drug classes enriched for association with PULMONARY LYMPHOMATOID GRANULOMATOSIS